Search bioRxiv⌕ Search

Biology subjects

Wang, H.-D.

Publications and source records attributed to Wang, H.-D..

2 recordsLinked to original sources

Phosphatidylinositol Transfer Protein-1 Integrates Insulin/IGF-1 and TOR Signaling to Negatively Regulate Lifespan and Healthspan in Caenorhabditis elegans

BackgroundPhosphatidylinositol transfer protein-1 (pitp-1) is involved in phosphoinositide turnover. The role of pitp-1 in promoting healthy longevity remains unknown. Our previous work showed that the phosphoinositide turnover genes dagl-1 and dgk-5 regulates lifespan, as overexpression of dagl-1 or knockdown of dgk-5 prolongs lifespan and enhances oxidative stress resistance through TOR signaling. As pitp-1 is a key component of this pathway, we investigated its role in lifespan regulation and the underlying mechanisms, aiming to clarify whether it represents a critical regulator of healthy longevity and how it coordinates conserved signaling pathways to regulate aging. MethodsC. elegans mutants, RNAi-mediated knockdown, and transgenic overexpression were applied to assess lifespan, motility, stress resistance. Temporal and tissue-specific RNAi were applied to identify the critical time window and tissue for pitp-1-mediated lifespan regulation. TOR signaling was measured by phosphorylated S6 kinase and puromycin incorporation, and transcriptomic analysis identified affected pathways. Resultspitp-1 negatively regulates lifespan and healthspan in Caenorhabditis elegans. Genetic deletion or RNAi-mediated knockdown of pitp-1 extends lifespan, attenuates age-related motility decline, and increases oxidative stress resistance. Temporal and spatial analyses reveal that suppression of pitp-1 in neurons during early adulthood is sufficient to promote healthy longevity. Mechanistically, these beneficial effects upon pitp-1 reduction are mediated by suppressing TOR signaling. Conversely, pitp-1 overexpression shortens lifespan and impairs healthspan via TOR activation. Moreover, pitp-1 is transcriptionally repressed by DAF-16 downstream of insulin/IGF-1 signaling (IIS), and contributes to IIS-mediated lifespan extension. ConclusionThese findings identify pitp-1 as a novel regulator of healthy aging that integrates IIS and TOR pathways, providing new insights into conserved mechanisms for promoting healthy longevity.

genetics↗

Stabilization of AMPK/PFKL/RPIA in the Glycolytic Bodies Transduces IL6/STAT3 Signal in Hepatocarcinogenesis

Metabolic reprogramming is a pivotal characteristic of cancer, yet the intricate interplay between glycolysis and the pentose phosphate pathway (PPP) remains elusive. This study unveils the pivotal role of 6-phosphofructokinase liver type (PFKL) in glycolysis and ribose 5-phosphate isomerase A (RPIA) in PPP, orchestrating liver tumorigenesis. PFKL, the rate-limiting enzyme in glycolysis, stabilizes RPIA by impeding ubiquitination/proteasome activity. The pro-inflammatory and tumor cytokine interleukin 6 activates pSTAT3 which binds to the promoter region and activates AMPK and PFKL transcription. Furthermore, pAMPK stabilizes PFKL protein by preventing proteasome degradation in hepatoma cells. Inhibiting PFKL, AMPK, and STAT3 genetically or pharmacologically can reduce glycolysis, ATP production, resulting in reduction of hepatoma cell proliferation and migration. Intriguingly, the PFKL, AMPK, RPIA, and PKM2 are co-localized in the Glycolytic body (G-body) which starts forming at chronic hepatitis, dramatically increases during active hepatitis, and the size of G-bodies becomes bigger from cirrhosis to hepatocellular carcinoma. Furthermore, using Bimolecular fluorescence complementation (BiFC) assay, we demonstrated that PFKL and RPIA direct interacts. Targeting AMPK or STAT3 significantly reduced tumor formation and lipid accumulation in zebrafish models, suggesting the STAT3/AMPK/PFKL axis as a potential therapeutic avenue for liver cancer treatment.

cancer biology↗